Literature DB >> 30603119

The role of lineage specifiers in pancreatic ductal adenocarcinoma.

Soledad A Camolotto1, Veronika K Belova1, Eric L Snyder1,2.   

Abstract

Over the last decade, multiple genomics studies have led to the identification of discrete molecular subtypes of pancreatic ductal adenocarcinoma. A general theme has emerged that most pancreatic ductal adenocarcinoma (PDAC) can be grouped into two major subtypes based on cancer cell autonomous properties: classical/pancreatic progenitor and basal-like/squamous. The classical/progenitor subtype expresses higher levels of lineage specifiers that regulate endodermal differentiation than the basal-like/squamous subtype. The basal-like/squamous subtype confers a worse prognosis, raising the possibility that loss of these lineage specifiers might enhance the malignant potential of PDAC. Here, we discuss several of these differentially expressed lineage specifiers and examine the evidence that they might play a functional role in PDAC biology.

Entities:  

Keywords:  Lineage specifier; molecular subtype; transcription factor

Year:  2018        PMID: 30603119      PMCID: PMC6286940          DOI: 10.21037/jgo.2018.05.04

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  64 in total

1.  Foxa1 and Foxa2 regulate bile duct development in mice.

Authors:  Zhaoyu Li; Peter White; Geetu Tuteja; Nir Rubins; Sara Sackett; Klaus H Kaestner
Journal:  J Clin Invest       Date:  2009-05-11       Impact factor: 14.808

2.  Pdx1 expression in pancreatic precursor lesions and neoplasms.

Authors:  Jason Y Park; Seung-Mo Hong; David S Klimstra; Michael G Goggins; Anirban Maitra; Ralph H Hruban
Journal:  Appl Immunohistochem Mol Morphol       Date:  2011-10

3.  PDX-1: demonstration of oncogenic properties in pancreatic cancer.

Authors:  Shi-He Liu; Sanjeet Patel; Marie-Claude Gingras; John Nemunaitis; Guisheng Zhou; Changyi Chen; Min Li; William Fisher; Richard Gibbs; F Charles Brunicardi
Journal:  Cancer       Date:  2010-09-30       Impact factor: 6.860

4.  Dysregulated expression of P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha in the pathogenesis of human cancer.

Authors:  T Tanaka; S Jiang; H Hotta; K Takano; H Iwanari; K Sumi; K Daigo; R Ohashi; M Sugai; C Ikegame; H Umezu; Y Hirayama; Y Midorikawa; Y Hippo; A Watanabe; Y Uchiyama; G Hasegawa; Pc Reid; H Aburatani; T Hamakubo; J Sakai; M Naito; T Kodama
Journal:  J Pathol       Date:  2006-04       Impact factor: 7.996

5.  Hepatocyte nuclear factor 4alpha regulates the expression of pancreatic beta -cell genes implicated in glucose metabolism and nutrient-induced insulin secretion.

Authors:  H Wang; P Maechler; P A Antinozzi; K A Hagenfeldt; C B Wollheim
Journal:  J Biol Chem       Date:  2000-11-17       Impact factor: 5.157

Review 6.  Monogenic diabetes mellitus in youth. The MODY syndromes.

Authors:  W E Winter; M Nakamura; D V House
Journal:  Endocrinol Metab Clin North Am       Date:  1999-12       Impact factor: 4.741

7.  Foxa2 (HNF3beta ) controls multiple genes implicated in metabolism-secretion coupling of glucose-induced insulin release.

Authors:  Haiyan Wang; Benoit R Gauthier; Kerstin A Hagenfeldt-Johansson; Mariella Iezzi; Claes B Wollheim
Journal:  J Biol Chem       Date:  2002-03-01       Impact factor: 5.157

8.  Loss of FOXA1/2 is essential for the epithelial-to-mesenchymal transition in pancreatic cancer.

Authors:  Yan Song; M Kay Washington; Howard C Crawford
Journal:  Cancer Res       Date:  2010-02-16       Impact factor: 12.701

9.  Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4alpha gene.

Authors:  Chuan Yin; Yong Lin; Xin Zhang; Yue-Xiang Chen; Xin Zeng; Hai-Yan Yue; Jun-Liang Hou; Xing Deng; Jun-Ping Zhang; Ze-Guang Han; Wei-Fen Xie
Journal:  Hepatology       Date:  2008-11       Impact factor: 17.425

10.  Identification of an inter-transcription factor regulatory network in human hepatoma cells by Matrix RNAi.

Authors:  Yasuhiro Tomaru; Misato Nakanishi; Hisashi Miura; Yasumasa Kimura; Hiroki Ohkawa; Yusuke Ohta; Yoshihide Hayashizaki; Masanori Suzuki
Journal:  Nucleic Acids Res       Date:  2009-01-07       Impact factor: 16.971

View more
  5 in total

1.  Reciprocal regulation of pancreatic ductal adenocarcinoma growth and molecular subtype by HNF4α and SIX1/4.

Authors:  Soledad A Camolotto; Veronika K Belova; Luke Torre-Healy; Jeffery M Vahrenkamp; Kristofer C Berrett; Hannah Conway; Jill Shea; Chris Stubben; Richard Moffitt; Jason Gertz; Eric L Snyder
Journal:  Gut       Date:  2020-08-21       Impact factor: 23.059

Review 2.  Cell Lineage Infidelity in PDAC Progression and Therapy Resistance.

Authors:  Antonia Malinova; Lisa Veghini; Francisco X Real; Vincenzo Corbo
Journal:  Front Cell Dev Biol       Date:  2021-12-02

3.  Establishment of a reference single-cell RNA sequencing dataset for human pancreatic adenocarcinoma.

Authors:  Ryota Chijimatsu; Shogo Kobayashi; Yu Takeda; Masatoshi Kitakaze; Shotaro Tatekawa; Yasuko Arao; Mika Nakayama; Naohiro Tachibana; Taku Saito; Daisuke Ennishi; Shuta Tomida; Kazuki Sasaki; Daisaku Yamada; Yoshito Tomimaru; Hidenori Takahashi; Daisuke Okuzaki; Daisuke Motooka; Takahito Ohshiro; Masateru Taniguchi; Yutaka Suzuki; Kazuhiko Ogawa; Masaki Mori; Yuichiro Doki; Hidetoshi Eguchi; Hideshi Ishii
Journal:  iScience       Date:  2022-06-22

4.  Pancreatic Cancer Cells Induce MicroRNA Deregulation in Platelets.

Authors:  Jorge Yassen Díaz-Blancas; Ismael Dominguez-Rosado; Carlos Chan-Nuñez; Jorge Melendez-Zajgla; Vilma Maldonado
Journal:  Int J Mol Sci       Date:  2022-09-28       Impact factor: 6.208

Review 5.  The Role of lncRNAs in the Stem Phenotype of Pancreatic Ductal Adenocarcinoma.

Authors:  Jorge Melendez-Zajgla; Vilma Maldonado
Journal:  Int J Mol Sci       Date:  2021-06-15       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.